Cargando…

Estrogen receptor subcellular localization and cardiometabolism

BACKGROUND: In addition to their crucial role in reproduction, estrogens are key regulators of energy and glucose homeostasis and they also exert several cardiovascular protective effects. These beneficial actions are mainly mediated by estrogen receptor alpha (ERα), which is widely expressed in met...

Descripción completa

Detalles Bibliográficos
Autores principales: Gourdy, Pierre, Guillaume, Maeva, Fontaine, Coralie, Adlanmerini, Marine, Montagner, Alexandra, Laurell, Henrik, Lenfant, Françoise, Arnal, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066739/
https://www.ncbi.nlm.nih.gov/pubmed/29807870
http://dx.doi.org/10.1016/j.molmet.2018.05.009
_version_ 1783343023377088512
author Gourdy, Pierre
Guillaume, Maeva
Fontaine, Coralie
Adlanmerini, Marine
Montagner, Alexandra
Laurell, Henrik
Lenfant, Françoise
Arnal, Jean-François
author_facet Gourdy, Pierre
Guillaume, Maeva
Fontaine, Coralie
Adlanmerini, Marine
Montagner, Alexandra
Laurell, Henrik
Lenfant, Françoise
Arnal, Jean-François
author_sort Gourdy, Pierre
collection PubMed
description BACKGROUND: In addition to their crucial role in reproduction, estrogens are key regulators of energy and glucose homeostasis and they also exert several cardiovascular protective effects. These beneficial actions are mainly mediated by estrogen receptor alpha (ERα), which is widely expressed in metabolic and vascular tissues. As a member of the nuclear receptor superfamily, ERα was primarily considered as a transcription factor that controls gene expression through the activation of its two activation functions (ERαAF-1 and ERαAF-2). However, besides these nuclear actions, a pool of ERα is localized in the vicinity of the plasma membrane, where it mediates rapid signaling effects called membrane-initiated steroid signals (MISS) that have been well described in vitro, especially in endothelial cells. SCOPE OF THE REVIEW: This review aims to summarize our current knowledge of the mechanisms of nuclear vs membrane ERα activation that contribute to the cardiometabolic protection conferred by estrogens. Indeed, new transgenic mouse models (affecting either DNA binding, activation functions or membrane localization), together with the use of novel pharmacological tools that electively activate membrane ERα effects recently allowed to begin to unravel the different modes of ERα signaling in vivo. CONCLUSION: Altogether, available data demonstrate the prominent role of ERα nuclear effects, and, more specifically, of ERαAF-2, in the preventive effects of estrogens against obesity, diabetes, and atheroma. However, membrane ERα signaling selectively mediates some of the estrogen endothelial/vascular effects (NO release, reendothelialization) and could also contribute to the regulation of energy balance, insulin sensitivity, and glucose metabolism. Such a dissection of ERα biological functions related to its subcellular localization will help to understand the mechanism of action of “old” ER modulators and to design new ones with an optimized benefit/risk profile.
format Online
Article
Text
id pubmed-6066739
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60667392018-08-01 Estrogen receptor subcellular localization and cardiometabolism Gourdy, Pierre Guillaume, Maeva Fontaine, Coralie Adlanmerini, Marine Montagner, Alexandra Laurell, Henrik Lenfant, Françoise Arnal, Jean-François Mol Metab Review BACKGROUND: In addition to their crucial role in reproduction, estrogens are key regulators of energy and glucose homeostasis and they also exert several cardiovascular protective effects. These beneficial actions are mainly mediated by estrogen receptor alpha (ERα), which is widely expressed in metabolic and vascular tissues. As a member of the nuclear receptor superfamily, ERα was primarily considered as a transcription factor that controls gene expression through the activation of its two activation functions (ERαAF-1 and ERαAF-2). However, besides these nuclear actions, a pool of ERα is localized in the vicinity of the plasma membrane, where it mediates rapid signaling effects called membrane-initiated steroid signals (MISS) that have been well described in vitro, especially in endothelial cells. SCOPE OF THE REVIEW: This review aims to summarize our current knowledge of the mechanisms of nuclear vs membrane ERα activation that contribute to the cardiometabolic protection conferred by estrogens. Indeed, new transgenic mouse models (affecting either DNA binding, activation functions or membrane localization), together with the use of novel pharmacological tools that electively activate membrane ERα effects recently allowed to begin to unravel the different modes of ERα signaling in vivo. CONCLUSION: Altogether, available data demonstrate the prominent role of ERα nuclear effects, and, more specifically, of ERαAF-2, in the preventive effects of estrogens against obesity, diabetes, and atheroma. However, membrane ERα signaling selectively mediates some of the estrogen endothelial/vascular effects (NO release, reendothelialization) and could also contribute to the regulation of energy balance, insulin sensitivity, and glucose metabolism. Such a dissection of ERα biological functions related to its subcellular localization will help to understand the mechanism of action of “old” ER modulators and to design new ones with an optimized benefit/risk profile. Elsevier 2018-05-16 /pmc/articles/PMC6066739/ /pubmed/29807870 http://dx.doi.org/10.1016/j.molmet.2018.05.009 Text en © 2018 Published by Elsevier GmbH. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review
Gourdy, Pierre
Guillaume, Maeva
Fontaine, Coralie
Adlanmerini, Marine
Montagner, Alexandra
Laurell, Henrik
Lenfant, Françoise
Arnal, Jean-François
Estrogen receptor subcellular localization and cardiometabolism
title Estrogen receptor subcellular localization and cardiometabolism
title_full Estrogen receptor subcellular localization and cardiometabolism
title_fullStr Estrogen receptor subcellular localization and cardiometabolism
title_full_unstemmed Estrogen receptor subcellular localization and cardiometabolism
title_short Estrogen receptor subcellular localization and cardiometabolism
title_sort estrogen receptor subcellular localization and cardiometabolism
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066739/
https://www.ncbi.nlm.nih.gov/pubmed/29807870
http://dx.doi.org/10.1016/j.molmet.2018.05.009
work_keys_str_mv AT gourdypierre estrogenreceptorsubcellularlocalizationandcardiometabolism
AT guillaumemaeva estrogenreceptorsubcellularlocalizationandcardiometabolism
AT fontainecoralie estrogenreceptorsubcellularlocalizationandcardiometabolism
AT adlanmerinimarine estrogenreceptorsubcellularlocalizationandcardiometabolism
AT montagneralexandra estrogenreceptorsubcellularlocalizationandcardiometabolism
AT laurellhenrik estrogenreceptorsubcellularlocalizationandcardiometabolism
AT lenfantfrancoise estrogenreceptorsubcellularlocalizationandcardiometabolism
AT arnaljeanfrancois estrogenreceptorsubcellularlocalizationandcardiometabolism